Abernethy Malformation and Gastrointestinal Bleeding: A Case Report and Literature Review

Wenrui Li1, Bin Liu1, Hai Feng1

  • 1Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

PubMed

Insights

Congenital extrahepatic portosystemic shunt (CEPS), or Abernethy malformation, is rare. Both surgical and endovascular closures are effective for CEPS, but high shunt flow may require additional treatment beyond coil embolization.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Pediatric Surgery

Background:

  • Congenital extrahepatic portosystemic shunt (CEPS), known as Abernethy malformation (AF), is a rare splanchnic venous system anomaly.
  • Current treatment strategies for CEPS, including surgical, radiological, and transplantation methods, lack comparative data.
  • This study presents a unique case of AF with an unusual shunt between the inferior mesenteric vein and the right ovarian vein.

Observation:

  • A literature review identified 34 AF patients with gastrointestinal (GI) tract bleeding.
  • Type II AF accounted for a significant majority (79%) of these GI bleeding cases.
  • The case report details an atypical shunt connection involving the inferior mesenteric vein and the right ovarian vein.

Findings:

  • Both surgical ligation and endovascular shunt closure demonstrate efficacy and safety in managing AF.
  • Endovascular methods, particularly coil embolization, may be insufficient for complete shunt closure in cases with high shunt flow.
  • The study highlights the diverse clinical presentations of AF, including rare vascular connections.

Implications:

  • Surgical and endovascular approaches are viable treatments for CEPS, offering effective management options.
  • Clinicians should consider the shunt flow dynamics when selecting endovascular treatment, as additional measures may be necessary.
  • Further research comparing different CEPS treatment modalities is warranted to establish optimal therapeutic guidelines.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
51
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
153
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
90
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
46